about
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsMolecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxenNew insights into the use of currently available non-steroidal anti-inflammatory drugsNaproxen induces type X collagen expression in human bone-marrow-derived mesenchymal stem cells through the upregulation of 5-lipoxygenaseNonsteroidal anti-inflammatory drugs and cardiovascular safety - translating pharmacological data into clinical readouts.Major urinary metabolites of 6-keto-prostaglandin F2α in mice.Mechanistic and pharmacological issues of aspirin as an anticancer agent.Managing the adverse effects of nonsteroidal anti-inflammatory drugs.Osteoarthritis of the hand II: chemistry, pharmacokinetics and pharmacodynamics of naproxen, and clinical outcome studies.Prostanoids and NSAIDs in cardiovascular biology and disease.Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective.Coxibs, Traditional NSAIDs, and Cardiovascular Safety Post-PRECISION: What We Thought We Knew Then and What We Think We Know Now.Pharmacokinetic-pharmacodynamic modeling of the inhibitory effects of naproxen on the time-courses of inflammatory pain, fever, and the ex vivo synthesis of TXB2 and PGE2 in rats.The Prevalence of Symptomatic Deep Venous Thrombosis and Pulmonary Embolism After Anterior Cruciate Ligament Reconstruction.Model-based prediction of the acute and long-term safety profile of naproxen in rats.Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention.Determination of Potential Impurities of Naproxen Sodium in Soft Gelatin Capsules Dosage by Using Ultra Performance Liquid Chromatography
P2860
Q24619410-3024C57A-5679-4892-A030-4FDAD34301A8Q24621123-B6CC99D6-F4E6-4E13-90EA-1F8E91C6AD83Q26852330-9AA857D4-561F-4414-8BDC-F3AF1ED881FBQ34938495-CD8828EE-9DCB-4966-BCA6-B1C6EFDFE869Q36388949-87976C39-4995-40E9-83E5-D4BC929DE130Q36920598-D7C57189-4519-4063-8ECB-F7F286E6247CQ37277350-3B4B2D5E-B34E-4315-A533-A1211C8AA107Q37960540-6AFB2108-DEFD-4AF5-9ED8-DC4672A6002BQ38157117-3944760A-9EB8-45AB-BD79-7FEB3F7AAA09Q38504675-EA459AB4-2220-405E-8185-14FCBFC64A3CQ38851488-68D57B1B-D4D8-4DC9-BACE-B803F426FDDDQ39221288-413A82F9-F21B-4E8B-AEB1-043ED0CE2967Q40332994-06F09D1A-8331-41C4-A622-1AFCDBFE8D96Q40517300-8FBDA96B-B5C8-4B62-B46C-3BF948D1D2F3Q41056910-B30179DA-CFA2-497D-B7B1-6AB43DD13033Q55105263-EDDE846B-D497-4260-AD9D-7FE4B63C1F0FQ58164769-2F13FE11-DDB6-4803-A1B3-D3E29F1203BA
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Human pharmacology of naproxen sodium
@ast
Human pharmacology of naproxen sodium
@en
Human pharmacology of naproxen sodium
@nl
type
label
Human pharmacology of naproxen sodium
@ast
Human pharmacology of naproxen sodium
@en
Human pharmacology of naproxen sodium
@nl
prefLabel
Human pharmacology of naproxen sodium
@ast
Human pharmacology of naproxen sodium
@en
Human pharmacology of naproxen sodium
@nl
P2093
P356
P1476
Human pharmacology of naproxen sodium
@en
P2093
Gabriele Merciaro
Luigia Di Francesco
Maria G Sciulli
Marta L Capone
Paola Anzellotti
Paola Patrignani
P304
P356
10.1124/JPET.107.122283
P407
P577
2007-08-01T00:00:00Z